Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.73544 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.69692 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.70384 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.66692 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.63891 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.77793 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.72761 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.66804 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.65722 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.68998 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.68401 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66161 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.70349 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.68999 | 31 |